David F. Torchiana, MD, CEO of Boston-based Partners HealthCare, has announced his plans to retire, The Boston Globe reported. 

Sky-high medical bills have forced many individuals to turn to crowdsourcing to pay what they owe, according to the CEO of GoFundMe, who spoke on CBS MoneyWatch.

Planned hip and knee replacements are on the rise in the U.S., including among younger Americans, according to an analysis from the Blue Cross Blue Shield Association (BCBSA).

IBM, Aetna, Anthem, Health Care Service Corporation and PNC Bank are working together to design and create a blockchain network to improve transparency and interoperability in the healthcare industry, the companies announced.

Dartmouth-Hitchcock Health, a New Hampshire-based health system that serves 1.9 million people across New England, and GraniteOne Health, a network of New Hampshire hospitals, have signed a letter of intent to merge.

Mandating pharmaceutical companies to disclose drug prices as part of Direct-to-Consumer Pharmaceutical Advertising (DTCPA) may reduce consumer interest in high-priced drugs. But the inclusion of modifiers indicating consumers will have zero out-of-pocket costs weakened the finding, according to the results of a behavioral experiment published in JAMA Internal Medicine. 

Tencent, a Chinese multinational investment holding conglomerate, and Merck KGaA, a German-based pharmaceutical, life sciences and technology company, are collaborating to increase disease awareness and provide more accessible healthcare services via digital platforms in China by leveraging AI and big data.

Five major pharmaceutical companies could each lose $500 million or more in revenue per year if a proposal from the Trump administration to reimburse Medicare Part B drugs based on an international pricing index (IPI) is finalized.